Case report: Heterogenous SMARCA4-deficient thoracic non-small cell lung carcinoma with various responses to nivolumab

SMARCA4-deficient non-small cell carcinoma is an aggressive neoplasm with poor outcome. Several studies have highlighted its immunochemistry, pathophysiology, and underlying mechanisms, but studies of its definite treatment are few. Here, we report on a 69-year-old male with heterogenous pathologica...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Yun-Tzu, Li, Chien-Feng, Wu, Hung-Chang, Jan, Yi-Hua, Kuo, Yu-Hsuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083322/
https://www.ncbi.nlm.nih.gov/pubmed/37051241
http://dx.doi.org/10.3389/fimmu.2023.1131448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10083322/
https://www.ncbi.nlm.nih.gov/pubmed/37051241
http://dx.doi.org/10.3389/fimmu.2023.1131448

Ejemplares similares